Leukemia and sepsis are different, they are not the same thing

Share This Post

People who know nothing about leukemia are the most frightened. They will definitely mix sepsis and leukemia. They think this is a disease. In fact, these are two different diseases. Leukemia is more serious than sepsis. It is called blood cancer. Leukemia can only be matched by bone marrow, but sepsis is a condition caused by external wounds, and it must not be confused, so that correct and favorable judgment can be made when the disease is discovered.

Septicemia is mostly caused by trauma. Severe trauma has not been completely treated. Bacteria invade the blood and multiply in it, producing serious diseases caused by endotoxin and exotoxin. The main clinical manifestations are chills, high fever, various rashes, hepatosplenomegaly, toxic hepatitis and myocarditis, abdominal distension, vomiting, blood in the stool, headache, coma, etc. If there are multiple abscesses in the whole body, it is called sepsis. Severe patients can find white blood cells increased by routine examination (can also be reduced in severe cases), and more than two blood cultures can cultivate the same bacteria.

Leukemia, commonly referred to as “blood cancer,” is a malignant disease of the hematopoietic system caused by viral infection or exposure to radiation, chemical poisons, and so on. The main clinical manifestations are fever, nosebleeds, gum bleeding, gastrointestinal bleeding and so on. In addition, there is bone and joint pain, headache, liver and spleen and lymphadenopathy, testicular swelling and pain. Finding leukemia cells by bone marrow aspiration is the basis for diagnosis.

In theory, leukemia is more serious than sepsis, because the patient’s hematopoietic function is affected, and once the wound appears, it is very difficult to heal. Septicemia can usually be cured after selecting the appropriate antibiotic treatment, and leukemia can be cured after a long period of treatment, and if it is not paid attention to in later care, it is easy to relapse.

For leukemia, in addition to bone marrow matching, there is also a type of cellular immunotherapy. From the body, patients with immune cells that fight against foreign bodies such as cancer cells and viruses are taken out of the blood, cultured in the laboratory to increase the number, and return to After the body, the patient’s immune power is restored again, and the treatment method of attacking the tumor is now. The standard treatment is to kill the cancer cells from the external force, and the normal cells will also be killed or injured. The cancer immune cell treatment is to use the patient’s own Of immune cells attack cancer cells, will not attack normal cells, have no side effects, and can also be used in conjunction with the three standard therapies. Recent studies have shown that immune cell therapy can improve the effectiveness of the three standard treatments, improve patient survival, and improve The patient’s quality of life.

It can be seen that leukemia and sepsis are two completely different diseases, one directly threatens life, and the other is indeed highly likely to be cured, but no matter what kind of impact on the body can not be underestimated, patients Only by actively cooperating with the treatment can your body recover slowly and gradually.


For details on lymphoma treatment and second opinion, do call us at +91 96 1588 1588 or write to cancerfax@gmail.com.

Spread the love

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Development of CAR T Cell therapy in Korea
Cancer treatment in South Korea

Companies in Korea takes a step closer in developing home grown CAR T-Cell therapy

Due to high costs, treatments developed by multinational pharmaceutical corporations are difficult for Korean patients to access. As a result, Korean businesses have created and localised CAR-T treatments in an effort to address these issues. Many businesses have either begun developing CAR-T therapies or declared their intention to do so, including Curocell, Abclon, GC Cell, Ticaros, Helixmith, Toolgen, Cllengene, Eutilex, and Vaxcell Bio.

Spread the love
Blood cancer

Polatuzumab vedotin-piiq is approved by USFDA for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously received treatment and who have an International Prognostic Index (IPI) score of 2 or higher, the Food and Drug Administration has approved polatuzumab vedotin-piiq (Polivy, Genentech, Inc.).

Spread the love

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

درمان سرطان در تركيه

Enquiry Form